Skip to main content
. 2019 Mar;40(3):412–417. doi: 10.3174/ajnr.A5958

Fig 2.

Fig 2.

Gd-C T1WI for CRN from nasopharyngeal carcinoma (A), predominant (>80%) CRN (B), predominant recurrent tumor (<20% CRN) (C), and glioblastoma (0% CRN) (D), and the corresponding COLLAGE entropy maps of the ROIs (E–H).

HHS Vulnerability Disclosure